Antiglomerular basement membrane disease with normal renal function

Kidney International

Volumn 72, Issue 11, 2007, Pages 1403-1408

  Cui, Z ^a   Zhao, M H ^a   Singh, A K ^b   Wang, H Y ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLOMERULUS BASEMENT MEMBRANE ANTIBODY; PREDNISONE;

ADULT; ANTIGLOMERULUS BASEMENT MEMBRANE DISEASE; ARTICLE; CASE REPORT; CIGARETTE SMOKING; CLINICAL FEATURE; COUGHING; DRUG DOSE REDUCTION; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULOPATHY; GLOMERULUS BASEMENT MEMBRANE; GOODPASTURE SYNDROME; HEART FAILURE; HEMOPTYSIS; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FUNCTION; LIVER FUNCTION; LUNG INFECTION; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; SMALL VESSEL VASCULITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUBERCULOSIS; URINALYSIS;

EID: 36249006564     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002525     Document Type: Article

References (28)

1. Falk RJ, Jennette C, Nachman PH. Primary glomerular diseases. In: Brenner BM, Rector Jr FC (eds). The Kidney, 7th edn. WB Saunders: Philadelphia, 2004, pp 1293-1380.
2. Jindal KK. Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: evidence-based recommendation. Kidney Int 1999; 70(Suppl): S33-S40.
3. Levy JB, Turner AN, Rees AJ et al. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001; 134: 1033-1042.
4. Mathew TM, Hobbs JB, Kalowski S et al. Goodpasture's syndrome: normal renal diagnostic findings. Ann Intern Med 1975; 82: 215-218.
5. Bell DD, Moffatt SL, Singer M, Munt PW. Antibasement membrane antibody disease without clinical evidence of renal disease. Am Rev Resp Dis 1990; 142: 234-237.
6. Lamriben L, Kourilsky O, Mougenot B et al. Goodpasture's syndrome with asymptomatic renal involvement. Disappearance of antiglomerular basement membrane antibodies after treatment. Nephrol Dial Transplant 1993; 8: 1267-1269.
7. Zimmerman SW, Varanasi UR, Hoff B. Goodpasture's syndrome with normal renal function. Am J Med 1979; 66: 163-171.
8. Bailey RR, Simpson IJ, Lynn KL et al. Goodpasture's syndrome with normal renal function. Clin Nephrol 1981; 15: 211-215.
9. Knoll G, Rabin E, Burns BF. Antiglomerular basement membrane antibody-mediated nephritis with normal pulmonary and renal function. Am J Nephrol 1993; 13: 494-496.
10. YoungMin SA, Rutherford P, Ward MK et al. Goodpasture's syndrome with normal renal function. Nephrol Dial Transplant 1996; 11: 2302-2305.
11. Ang C, Savige J, Dawborn J et al. Anti-glomerular basement membrane (GBM) antibody-mediated disease with normal renal function. Nephrol Dial Transplant 1998; 13: 935-939.
12. Cui Z, Zhao MH, Xin G et al. Characteristics and prognosis of Chinese patients with anti-glomerular basement membrane disease. Nephron Clin Pract 2005; 99: c49-c55.
13. Beirne GJ, Wagnild JP, Zimmerman SW et al. Idiopathic crescentic glomerulonephritis. Medicine 1977; 56: 349-381.
14. Walker RG, Scheinkestel C, Becker GJ et al. Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome. Q J Med 1985; 54: 75-89.
15. Donaghy M, Rees AJ. Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet 1983; 2: 1390-1394.
16. Daniell WE, Couser WG, Rosenstock L. Occupational solvent exposure and glomerulonephritis. A case report and review of the literature. JAMA 1988; 259: 2280-2283.
17. Teague CA, Doak PB, Simpson IJ et al. Goodpasture's syndrome: an analysis of 29 cases. Kidney Int 1978; 13: 492-504.
18. Cui Z, Wang HY, Zhao MH. Natural autoantibodies against glomerular basement membrane exist in normal human sera. Kidney Int 2006; 69: 894-899.
19. Hellmark T, Segelmark M, Unger C et al. Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease. Kidney Int 1999; 55: 936-944.
20. Salama AD, Levy JB, Lightstone L et al. Goodpasture's disease. Lancet 2001; 358: 917-920.
21. Bowman C, Ambrus K, Lockwood CM. Restriction of IgG subclass expression in the population of auto-antibodies to glomerular basement membrane. Clin Exp Immunol 1987; 69: 341-349.
22. NoÄl LH, Aucouturier P, Monteiro RC et al. Glomerular and serum immunoglobulin G subclasses in membranous nephropathy and anti-glomerular basement membrane nephritis. Clin Immunol Immunopathol 1988; 46: 186-194.
23. Yan Y, Cui Z, Zhao MH. The distribution and clinical significance of IgG subclasses of anti-glomerular basement membrane antibodies, (submitted).
24. Dougan T, Levy JB, Salama A et al. Characterization of autoantibodies from patients with Goodpasture's disease using a resonant mirror biosensor. Clin Exp Immunol 2002; 128: 555-561.
25. Segelmark M, Hellmark T, Wieslander J. The prognostic significance in Goodpasture's disease of specificity, titer and affinity of anti-glomerular- basement-membrane antibodies. Nephron Clin Pract 2003; 94: c59-c68.
26. Cui Z, Zhao MH. Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity. Clin Immunol 2005; 116: 77-82.
27. Friguet B, Chaffotte AF, Djavadi-Ohaniance L et al. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J Immunol Methods 1985; 77: 305-319.
28. Kalluri R, Wilson CB, Weber M et al. Identification of the a3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome. J Biol Chem 1995; 6: 1178-1185.